Cas:214852-61-6 z-d-dab(boc)-oh dcha manufacturer & supplier

We serve Chemical Name:z-d-dab(boc)-oh dcha CAS:214852-61-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

z-d-dab(boc)-oh dcha

Chemical Name:z-d-dab(boc)-oh dcha
CAS.NO:214852-61-6
Synonyms:(R)-2-Benzyloxycarbonylamino-4-(Boc-amino)butyric acid dicyclohexylammonium salt;Dicyclohexylamine (R)-2-(((benzyloxy)carbonyl)amino)-4-((tert-butoxycarbonyl)amino)butanoate;N-Cbz-N’-Boc-D-2,4-diaminobutyric acid dicyclohexylamine salt;Butanoic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-[[(phenylmethoxy)carbonyl]amino]-, (2R)-, compd. with N-cyclohexylcyclohexanamine (1:1);(2R)-4-({[(1,1-dimethylethyl)oxy]carbonyl}amino)-2-({[(phenylmethyl)oxy]carbonyl}amino)butanoic acid dicyclohexylamine salt;Z-D-DAB(BOC)-OH DCHA;(2R)-2-{[(Benzyloxy)carbonyl]amino}-4-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)butanoic acid – N-cyclohexylcyclohexanamine (1:1);I04-1233
Molecular Formula:C29H47N3O6
Molecular Weight:533.700
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:125.99000
Exact Mass:533.346497
LogP:6.69490

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (R)-2-Benzyloxycarbonylamino-4-(Boc-amino)butyric acid dicyclohexylammonium salt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,I04-1233 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-Cbz-N’-Boc-D-2,4-diaminobutyric acid dicyclohexylamine salt Use and application,Z-D-DAB(BOC)-OH DCHA technical grade,usp/ep/jp grade.


Related News: In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. z-d-dab(boc)-oh dcha manufacturer With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved. z-d-dab(boc)-oh dcha supplier Amanpour is based in London, and said she feels fortunate to have health insurance through work and incredible doctors who are treating me in a country underpinned by, of course, the brilliant NHS [National Health Service],” CNN reported.
“I want to applaud Christiane Amanpour for her candor, bravery and always working towards the greater good,” he said in a statement. “As a cancer survivor, I too encourage people to listen to their bodies and get all early cancer screenings available to them. z-d-dab(boc)-oh dcha vendor With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved. z-d-dab(boc)-oh dcha factory Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.